ArticleJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2025
Polypharmacy and deprescribing attitudes among stroke survivors: Opportunities for enhanced patient centered care.
Article in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trial
- A concept analysis of patient participation in medication safety among older adults with stroke in China: a hybrid model.BMC geriatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThis study aimed to 1) describe the burden of polypharmacy among stroke survivors compared to older adults without a history of stroke and 2) assess their attitudes towards deprescribing.
methodsThis is a cross-sectional study of US Medicare Beneficiaries aged ≥65 who participated in the National Health and Aging Trends Study. Polypharmacy was defined by the number of regular medications reported (no polypharmacy, ≤5; moderate, 6-10; severe, >10). Deprescribing attitudes were elicited from the Medication Attitudes Module. Ordinal and logistic regression assessed the associations between polypharmacy, history of stroke, and deprescribing attitudes, adjusting for falls and comorbidities.
resultsOf the 2073 respondents, 253 reported a prior stroke. Compared to older adults without a history of stroke, stroke survivors were more likely to report polypharmacy (moderate: 39.4 % vs 29.8 %; severe: 22.6 % vs 9.8 %; p < 0.01). Most stroke survivors (87.1 %) and older adults without stroke (89.0 %) would be willing to stop one or more medications. Polypharmacy had the strongest association with favorable attitudes toward deprescribing.
conclusionStroke survivors report greater polypharmacy than older adults without a history of stroke. Both groups overwhelmingly favor deprescribing. Stroke survivors represent a key population that would welcome and benefit from efforts to deprescribe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.